SUPN
Supernus Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$49.91
-0.55 ▼ -1.09%
🌙 3월 13일 4:25 PM ET (한국 3/14 05:25)
$49.90
-0.01 ▼ -0.02%
| Index | RUT | P/E | - | EPS (ttm) | -0.68 | Insider Own | 5.41% | Shs Outstand | 0.06B | Perf Week | -7.35% |
| Market Cap | 2.87B | Forward P/E | 14.17 | EPS next Y | 83.19% | Insider Trans | -7.47% | Shs Float | 0.05B | Perf Month | -2.79% |
| Enterprise Value | 2.61B | PEG | 0.83 | EPS next Q | 0.19 | Inst Own | 100.63% | Short Float | 7.49% | Perf Quarter | 8.12% |
| Income | -0.04B | P/S | 4 | EPS this Y | -40.54% | Inst Trans | -5.08% | Short Ratio | 5.49 | Perf Half Y | 6.97% |
| Sales | 0.72B | P/B | 2.7 | EPS next 5Y | 17.09% | ROA | -2.48% | Short Interest | 4.08M | Perf YTD | 0.42% |
| Book/sh | 18.48 | P/C | 9.31 | EPS past 3/5Y | - | ROE | -3.68% | 52W High | -16.37% ($59.68) | Perf Year | 60.12% |
| Cash/sh | 5.36 | P/FCF | 62.49 | Sales past 3/5Y | 2.52% 6.68% | ROIC | -3.53% | 52W Low | 71.16% ($29.16) | Perf 3Y | 42.64% |
| Dividend Est. | - | EV/EBITDA | 53.43 | EPS Y/Y TTM | -150.75% | Gross Margin | 76.9% | Volatility(W/M) | 4.04% 4.3% | Perf 5Y | 86.89% |
| Dividend TTM | - | EV/Sales | 3.63 | Sales Y/Y TTM | 8.63% | Oper. Margin | -5.95% | ATR (14) | 2.26 | Perf 10Y | 218.91% |
| Dividend Ex-Date | - | Quick Ratio | 1.66 | EPS Q/Q | -126.37% | Profit Margin | -5.36% | RSI (14) | 39.71 | Recom | 1.33 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.9 | Sales Q/Q | 21.48% | SMA20 | -5.87% ($53.02) | Beta | 0.74 | Target Price | $63.17 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2000000 | SMA50 | -2.48% ($51.18) | Rel Volume | 1.08 | Prev Close | $50.46 |
| Employees | 778 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 148.68% 8.41% | SMA200 | 11.66% ($44.7) | Avg Volume(3M) | 0.74M | Price | $49.91 |
| IPO | 2012/5/1 | Option/Short | Yes/Yes | Trades | 8119 | Volume | 802,078 | Change | -1.09% |
뉴스 로딩 중...